[Form 4] USANA Health Sciences Inc Insider Trading Activity
USANA Health Sciences (USNA) 鈥� Form 4 insider filing: Director Peggie Pelosi reported RSU vesting and related share withholding on 24 Jul 2025. She converted 1,058 restricted stock units (code 鈥淢鈥�), adding the same number of common shares at a $0 exercise price. To cover taxes, 606 shares were withheld/sold (code 鈥淔鈥�) at $32.09, leaving a net increase of 452 shares.
Following the transactions, Pelosi now directly owns 4,135 common shares and still holds 3,172 un-vested/vested RSUs. No open-market purchases or discretionary sales were disclosed; the activity reflects scheduled equity compensation vesting. No changes to company guidance, operations, or financial metrics were included.
USANA Health Sciences (USNA) 鈥� Comunicazione interna Modulo 4: La direttrice Peggie Pelosi ha riportato l'acquisizione di RSU e la relativa trattenuta di azioni il 24 luglio 2025. Ha convertito 1.058 unit脿 azionarie vincolate (codice 鈥淢鈥�), aggiungendo lo stesso numero di azioni ordinarie con un prezzo di esercizio di $0. Per coprire le tasse, sono state trattenute/vendute 606 azioni (codice 鈥淔鈥�) a $32,09, lasciando un aumento netto di 452 azioni.
Dopo queste operazioni, Pelosi possiede ora direttamente 4.135 azioni ordinarie e detiene ancora 3.172 RSU non maturate/mature. Non sono stati segnalati acquisti sul mercato aperto o vendite discrezionali; l'attivit脿 riflette la maturazione prevista del compenso azionario. Non sono stati comunicati cambiamenti nelle indicazioni aziendali, nelle operazioni o nei parametri finanziari.
USANA Health Sciences (USNA) 鈥� Presentaci贸n interna Formulario 4: La directora Peggie Pelosi inform贸 sobre la adquisici贸n de RSU y la retenci贸n de acciones relacionadas el 24 de julio de 2025. Ella convirti贸 1,058 unidades de acciones restringidas (c贸digo 鈥淢鈥�), sumando el mismo n煤mero de acciones comunes con un precio de ejercicio de $0. Para cubrir impuestos, se retuvieron/vendieron 606 acciones (c贸digo 鈥淔鈥�) a $32.09, dejando un aumento neto de 452 acciones.
Tras estas transacciones, Pelosi posee directamente 4,135 acciones comunes y a煤n mantiene 3,172 RSU no adquiridas/adquiridas. No se reportaron compras en mercado abierto ni ventas discrecionales; la actividad refleja la adquisici贸n programada de compensaci贸n en acciones. No se incluyeron cambios en la gu铆a de la compa帽铆a, operaciones o m茅tricas financieras.
USANA Health Sciences (USNA) 鈥� 雮措秬鞛� 氤搓碃靹� 鞏戩嫕 4: 鞚挫偓 韼橁赴 韼犽鞁滊姅 2025雲� 7鞗� 24鞚� RSU 旆摑 氚� 甏�霠� 欤检嫕 鞗愳矞歆曥垬毳� 氤搓碃頄堨姷雼堧嫟. 攴鸽厐電� 1,058臧滌潣 鞝滍暅 欤检嫕 雼渼(旖旊摐 鈥淢鈥�)毳� 鞝勴櫂頃橃棳 霃欖澕頃� 靾橃潣 氤错喌欤茧ゼ $0 頄夓偓臧�瓴╈溂搿� 於旉皜頄堨姷雼堧嫟. 靹戈笀 雮╇秬毳� 鞙勴暣 606欤缄皜 鞗愳矞歆曥垬/毵る弰(旖旊摐 鈥淔鈥�)霅橃柎 欤茧嫻 $32.09鞐� 觳橂Μ霅橃棃瓿�, 靾滌臧�電� 452欤检瀰雼堧嫟.
鞚� 瓯半灅 鞚错泟 韼犽鞁滊姅 歆侅爲 4,135欤检潣 氤错喌欤�毳� 靻岇湢頃橁碃 鞛堨溂氅�, 鞐爠頌� 3,172臧滌潣 氙疙檿鞝�/頇曥爼 RSU毳� 氤挫湢頃橁碃 鞛堨姷雼堧嫟. 瓿店皽 鞁滌灔 毵れ垬雮� 鞛勳潣 毵る弰電� 鞐嗢棃鞙茧┌, 鞚� 頇滊彊鞚� 鞓堨爼霅� 欤检嫕 氤挫儊 旆摑鞚� 氚橃榿頃╇媹雼�. 須岇偓 歆�旃�, 鞖挫榿 霕愲姅 鞛 歆�響滌棎 雽�頃� 氤�瓴� 靷暛鞚� 韽暔霅橃 鞎婌晿鞀惦媹雼�.
USANA Health Sciences (USNA) 鈥� D茅claration d鈥檌niti茅 Formulaire 4 : La directrice Peggie Pelosi a d茅clar茅 la consolidation de RSU et la retenue d鈥檃ctions associ茅e le 24 juillet 2025. Elle a converti 1 058 unit茅s d鈥檃ctions restreintes (code 芦 M 禄), ajoutant le m锚me nombre d鈥檃ctions ordinaires 脿 un prix d鈥檈xercice de 0 $. Pour couvrir les imp么ts, 606 actions ont 茅t茅 retenues/vendues (code 芦 F 禄) 脿 32,09 $, laissant une augmentation nette de 452 actions.
Suite 脿 ces transactions, Pelosi d茅tient d茅sormais directement 4 135 actions ordinaires et poss猫de toujours 3 172 RSU non acquises/acquises. Aucun achat sur le march茅 ouvert ni vente discr茅tionnaire n鈥檃 茅t茅 signal茅 ; cette activit茅 refl猫te la consolidation programm茅e de la r茅mun茅ration en actions. Aucun changement dans les pr茅visions de l鈥檈ntreprise, les op茅rations ou les indicateurs financiers n鈥檃 茅t茅 communiqu茅.
USANA Health Sciences (USNA) 鈥� Insider-Meldung Formular 4: Direktorin Peggie Pelosi meldete am 24. Juli 2025 die Freigabe von RSUs und die damit verbundene Aktieneinbehaltung. Sie wandelte 1.058 Restricted Stock Units (Code 鈥濵鈥�) um und erhielt dieselbe Anzahl an Stammaktien zu einem Aus眉bungspreis von 0 $. Zur Deckung der Steuern wurden 606 Aktien einbehalten/verkauft (Code 鈥濬鈥�) zu 32,09 $, was einen Nettomehrbestand von 452 Aktien ergibt.
Nach den Transaktionen besitzt Pelosi nun direkt 4.135 Stammaktien und h盲lt weiterhin 3.172 unverfallene/verfallene RSUs. Keine K盲ufe am offenen Markt oder diskretion盲re Verk盲ufe wurden gemeldet; die Aktivit盲t spiegelt die planm盲脽ige Freigabe der Aktienverg眉tung wider. Es wurden keine 脛nderungen an Unternehmensprognosen, Betrieb oder Finanzkennzahlen angegeben.
- None.
- None.
Insights
TL;DR: Routine RSU vesting; minor net share gain, neutral market impact.
The filing shows a standard quarterly RSU tranche converting into 1,058 shares, with 606 shares withheld for taxes. The net 452-share increase leaves the director鈥檚 direct stake at roughly 0.02 % of USNA鈥檚 ~19 M shares outstanding鈥攊mmaterial in ownership or signaling terms. Because the shares were not bought on the open market, the action offers limited insight into management鈥檚 valuation view. No derivative leverage or unusual codes appear. I categorize the filing as not impactful for valuation or liquidity.
TL;DR: Scheduled equity vesting; complies with Section 16, no governance red flags.
The Form 4 conforms to expected disclosure timing (within two business days). Transaction codes M and F indicate conversion and tax withholding, typical for equity plans. Remaining RSUs vest quarterly through Apr 2026, signaling predictable dilution of <1 bp per tranche. No 10 % ownership, pledging, or related-party issues are present. Governance risk remains unchanged; shareholders should view the event as routine administrative reporting.
USANA Health Sciences (USNA) 鈥� Comunicazione interna Modulo 4: La direttrice Peggie Pelosi ha riportato l'acquisizione di RSU e la relativa trattenuta di azioni il 24 luglio 2025. Ha convertito 1.058 unit脿 azionarie vincolate (codice 鈥淢鈥�), aggiungendo lo stesso numero di azioni ordinarie con un prezzo di esercizio di $0. Per coprire le tasse, sono state trattenute/vendute 606 azioni (codice 鈥淔鈥�) a $32,09, lasciando un aumento netto di 452 azioni.
Dopo queste operazioni, Pelosi possiede ora direttamente 4.135 azioni ordinarie e detiene ancora 3.172 RSU non maturate/mature. Non sono stati segnalati acquisti sul mercato aperto o vendite discrezionali; l'attivit脿 riflette la maturazione prevista del compenso azionario. Non sono stati comunicati cambiamenti nelle indicazioni aziendali, nelle operazioni o nei parametri finanziari.
USANA Health Sciences (USNA) 鈥� Presentaci贸n interna Formulario 4: La directora Peggie Pelosi inform贸 sobre la adquisici贸n de RSU y la retenci贸n de acciones relacionadas el 24 de julio de 2025. Ella convirti贸 1,058 unidades de acciones restringidas (c贸digo 鈥淢鈥�), sumando el mismo n煤mero de acciones comunes con un precio de ejercicio de $0. Para cubrir impuestos, se retuvieron/vendieron 606 acciones (c贸digo 鈥淔鈥�) a $32.09, dejando un aumento neto de 452 acciones.
Tras estas transacciones, Pelosi posee directamente 4,135 acciones comunes y a煤n mantiene 3,172 RSU no adquiridas/adquiridas. No se reportaron compras en mercado abierto ni ventas discrecionales; la actividad refleja la adquisici贸n programada de compensaci贸n en acciones. No se incluyeron cambios en la gu铆a de la compa帽铆a, operaciones o m茅tricas financieras.
USANA Health Sciences (USNA) 鈥� 雮措秬鞛� 氤搓碃靹� 鞏戩嫕 4: 鞚挫偓 韼橁赴 韼犽鞁滊姅 2025雲� 7鞗� 24鞚� RSU 旆摑 氚� 甏�霠� 欤检嫕 鞗愳矞歆曥垬毳� 氤搓碃頄堨姷雼堧嫟. 攴鸽厐電� 1,058臧滌潣 鞝滍暅 欤检嫕 雼渼(旖旊摐 鈥淢鈥�)毳� 鞝勴櫂頃橃棳 霃欖澕頃� 靾橃潣 氤错喌欤茧ゼ $0 頄夓偓臧�瓴╈溂搿� 於旉皜頄堨姷雼堧嫟. 靹戈笀 雮╇秬毳� 鞙勴暣 606欤缄皜 鞗愳矞歆曥垬/毵る弰(旖旊摐 鈥淔鈥�)霅橃柎 欤茧嫻 $32.09鞐� 觳橂Μ霅橃棃瓿�, 靾滌臧�電� 452欤检瀰雼堧嫟.
鞚� 瓯半灅 鞚错泟 韼犽鞁滊姅 歆侅爲 4,135欤检潣 氤错喌欤�毳� 靻岇湢頃橁碃 鞛堨溂氅�, 鞐爠頌� 3,172臧滌潣 氙疙檿鞝�/頇曥爼 RSU毳� 氤挫湢頃橁碃 鞛堨姷雼堧嫟. 瓿店皽 鞁滌灔 毵れ垬雮� 鞛勳潣 毵る弰電� 鞐嗢棃鞙茧┌, 鞚� 頇滊彊鞚� 鞓堨爼霅� 欤检嫕 氤挫儊 旆摑鞚� 氚橃榿頃╇媹雼�. 須岇偓 歆�旃�, 鞖挫榿 霕愲姅 鞛 歆�響滌棎 雽�頃� 氤�瓴� 靷暛鞚� 韽暔霅橃 鞎婌晿鞀惦媹雼�.
USANA Health Sciences (USNA) 鈥� D茅claration d鈥檌niti茅 Formulaire 4 : La directrice Peggie Pelosi a d茅clar茅 la consolidation de RSU et la retenue d鈥檃ctions associ茅e le 24 juillet 2025. Elle a converti 1 058 unit茅s d鈥檃ctions restreintes (code 芦 M 禄), ajoutant le m锚me nombre d鈥檃ctions ordinaires 脿 un prix d鈥檈xercice de 0 $. Pour couvrir les imp么ts, 606 actions ont 茅t茅 retenues/vendues (code 芦 F 禄) 脿 32,09 $, laissant une augmentation nette de 452 actions.
Suite 脿 ces transactions, Pelosi d茅tient d茅sormais directement 4 135 actions ordinaires et poss猫de toujours 3 172 RSU non acquises/acquises. Aucun achat sur le march茅 ouvert ni vente discr茅tionnaire n鈥檃 茅t茅 signal茅 ; cette activit茅 refl猫te la consolidation programm茅e de la r茅mun茅ration en actions. Aucun changement dans les pr茅visions de l鈥檈ntreprise, les op茅rations ou les indicateurs financiers n鈥檃 茅t茅 communiqu茅.
USANA Health Sciences (USNA) 鈥� Insider-Meldung Formular 4: Direktorin Peggie Pelosi meldete am 24. Juli 2025 die Freigabe von RSUs und die damit verbundene Aktieneinbehaltung. Sie wandelte 1.058 Restricted Stock Units (Code 鈥濵鈥�) um und erhielt dieselbe Anzahl an Stammaktien zu einem Aus眉bungspreis von 0 $. Zur Deckung der Steuern wurden 606 Aktien einbehalten/verkauft (Code 鈥濬鈥�) zu 32,09 $, was einen Nettomehrbestand von 452 Aktien ergibt.
Nach den Transaktionen besitzt Pelosi nun direkt 4.135 Stammaktien und h盲lt weiterhin 3.172 unverfallene/verfallene RSUs. Keine K盲ufe am offenen Markt oder diskretion盲re Verk盲ufe wurden gemeldet; die Aktivit盲t spiegelt die planm盲脽ige Freigabe der Aktienverg眉tung wider. Es wurden keine 脛nderungen an Unternehmensprognosen, Betrieb oder Finanzkennzahlen angegeben.
FAQ
How many USNA shares did Peggie Pelosi acquire on 24 July 2025?
Did the director sell any shares in this Form 4 filing?
What is Peggie Pelosi鈥檚 current direct ownership in USNA after the transaction?
Are there additional RSUs outstanding for the director?
Does the filing indicate any change in USANA鈥檚 financial outlook?
